LXR Blocking Peptide
Catalog number
3641BP-50
Name
LXR Blocking Peptide
Size
50 μg
Price
245.00 EUR
Supplier
Details
Antibody Target
LXR
Accession
Q13133
Gene ID
10062
Appearance
Colorless liquid
Concentration
0.5 mg/ml
Formulation
50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.
Packaging
EA
Storage Temp.
-20 °C
Shipping
gel pack
Shelf Life
1 year
Category
LXR
Research Use
For Rersearch Use Only! Not to be used in humans.
Handling
The peptide solution should be gently mixed before use.
Test
You can block the antibody by the specific target amino acid sequence of peptide.
Properties
blocking peptide
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
